APA (7th ed.) Citation

AP, J., I, R., CP, M., RS, B., DL, B., RW, C., . . . JW, M. (2020). Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted? Circulation, 142(16), 1579. https://doi.org/10.1161/CIRCULATIONAHA.120.045695

Chicago Style (17th ed.) Citation

AP, Jacobsen, Raber I, McCarthy CP, Blumenthal RS, Bhatt DL, Cusack RW, Serruys PWJC, Wijns W, and McEvoy JW. "Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted?" Circulation 142, no. 16 (2020): 1579. https://doi.org/10.1161/CIRCULATIONAHA.120.045695.

MLA (9th ed.) Citation

AP, Jacobsen, et al. "Lifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or Is Reappraisal Warranted?" Circulation, vol. 142, no. 16, 2020, p. 1579, https://doi.org/10.1161/CIRCULATIONAHA.120.045695.